Frontlight ResearchEarly access
WithdrawnNo phase
Using Virtual Reality Before Transcranial Magnetic Stimulation for the Treatment of OCD
Key facts
- Who runs it
- Yale University
- Where
- New Haven, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- May 2025
- Ended
- Dec 2025
- Type of study
- Interventional
- Treatments tested
- Virtual Reality
- Record updated
- 27 May 2026
- Why it stopped
- Study never initiaed.
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Participants must be at least 18 years old
- Patients must have been clinically evaluated by a Yale Interventional Psychiatry Service physician who has deemed them appropriate to receive TMS for the treatment of OCD
- Ability and willingness, in the investigator's judgement, to comply with the study procedure and study requirements
Who cannot take part
- Was previously enrolled/randomized into the study
- Hearing or visual impairment to the degree that would interfere with ability to see or hear VR content
- History of seizure disorder
- Dementia or other cognitive disorder or intellectual disability that would impair the subject's ability to understand the study procedure (per investigator judgment)
- Any other medical or psychiatric comorbidity that the investigator judges would put the participant at additional undue risk due to study participation or would impair subject's ability to participate in the study
- Difficulty in understanding spoken or written English
- Pregnancy
- Unable to provide informed consent
- Any implanted medical device, risk of interference with which by the VR device in the investigator's judgment can put patient at additional undue risk
Where in United States
- Yale Psychiatry Hospital Interventional Psychiatry Services (IPS) unitNew Haven, United States
About the trial
What the trial wants to find out
This study will focus on the use of Virtual Reality (VR) technology in patients receiving treatment using Transcranial Magnetic Stimulation (TMS) for Obsessive-Compulsive Disorder (OCD)
The group in the trial
- Treatment GroupTreatment being tested
This single arm will include all participants of the study, who will all receive the intervention
Treatment: Virtual Reality
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 27 May 2026